Altman Peter 4
4 · BioCardia, Inc. · Filed Apr 22, 2026
Research Summary
AI-generated summary of this filing
BioCardia (BCDA) CEO Peter Altman Buys 1,000 Shares
What Happened Peter Altman, President, CEO and a director of BioCardia, acquired a total of 1,000 common shares in two open-market purchases: 600 shares on 2026-04-20 and 400 shares on 2026-04-21. The reported weighted-average price for each day was $1.23, for a combined outlay of $1,230. These were purchases (not sales), which are generally viewed as a more direct indicator of insider buying activity than sales.
Key Details
- Transaction type: Open-market purchases (code P).
- Dates & prices:
- 2026-04-20 — 600 shares at a weighted average of $1.23 (actual trades ranged $1.22–$1.27) [Footnote F1].
- 2026-04-21 — 400 shares at a weighted average of $1.23 (actual trades ranged $1.21–$1.24) [Footnote F2].
- Total: 1,000 shares for $1,230.
- Shares owned after the transactions: not specified in the provided filing.
- Filing: Form 4 filed 2026-04-22 for trades on 4/20–4/21; this appears to be filed within the standard two-business-day window.
- Footnotes: The reported prices are weighted averages; the filer offers to provide per-trade details to the SEC or issuer on request.
Context These were small-dollar open-market purchases by the company's CEO (modest in size at $1.2k total), so while purchases can be a positive signal, the low dollar amount limits how much weight investors typically place on them. No options, gifts, or tax-withholding events are involved in these reported transactions.
Insider Transaction Report
- Purchase
Common Stock
[F1]2026-04-20$1.23/sh+600$738→ 275,366 total - Purchase
Common Stock
[F2]2026-04-21$1.23/sh+400$492→ 275,766 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades ranging from $1.22 to $1.27 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.
- [F2]This transaction was executed in multiple trades ranging from $1.21 to $1.24 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.